BC
WX

Bartlett & Co’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Bartlett & Co’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1,825
Closed -$71K – 774
2015
Q1 		$71K Hold
1,825
– – ﹤0.01% 373
2014
Q4 		$61K Hold
1,825
– – ﹤0.01% 402
2014
Q3 		$64K Hold
1,825
– – ﹤0.01% 391
2014
Q2 		$60K Hold
1,825
– – ﹤0.01% 415
2014
Q1 		$67K Buy
+1,825
New +$67K ﹤0.01% 384

Other funds holding WX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CGI
Comgest Global Investors Paris, France $4.59B AUM 12.96% 1-Year Est. Return
ACM
Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return

Bartlett & Co's WX Position: Q2 2015 in Review

Bartlett & Co sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q2 2015, closing a stake of 1,825 shares — an estimated $71K sold.

Bartlett & Co first reported a position in WX in Q1 2014 and held it in 5 quarters. The position peaked at $71K in Q1 2015. 154 funds tracked by Wall St. Rank hold WX as of Q2 2015.

  • Bartlett & Co reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q2 2015 after selling out during the quarter.
  • Bartlett & Co sold 1,825 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q2 2015, an estimated $71K.
  • Bartlett & Co first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q1 2014 and held it in 5 quarters.
  • Bartlett & Co's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $71K in Q1 2015.
  • 154 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q2 2015.

Based on Bartlett & Co's 13F filing for Q2 2015, filed 3 Aug 2015.